MD Anderson DAC

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001003989	Longitudinal biopsies from a melanoma patient who initially responded to MEK plus CDK4/6 inhibitor therapy were whole exome sequenced to identify potential resistance mutations. The biopsies included normal tissue, pre-treatment, on-treatment, and several post-resistance timepoints.	Illumina HiSeq 2500	6